Europe Nasal Delivery Devices Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country

No. of Pages: 134
Report Code: TIPRE00018195
Category: Life Sciences
Europe Nasal Delivery Devices Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Nasal Delivery Devices Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Nasal Delivery Devices Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Nasal Delivery Devices Market Regional Analysis

6.2 Europe Nasal Delivery Devices Market Revenue 2017-2027 (US$ Million)
6.3 Europe Nasal Delivery Devices Market Forecast Analysis

7. Europe Nasal Delivery Devices Market Analysis – by Drug Type

7.1 Anaesthetics
  • 7.1.1 Overview
  • 7.1.2 Anaesthetics: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Antibiotics
  • 7.2.1 Overview
  • 7.2.2 Antibiotics: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Pain Relief Drugs
  • 7.3.1 Overview
  • 7.3.2 Pain Relief Drugs: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Calcium Supplements
  • 7.4.1 Overview
  • 7.4.2 Calcium Supplements: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Vasoconstrictors
  • 7.5.1 Overview
  • 7.5.2 Vasoconstrictors: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Antihistamines
  • 7.6.1 Overview
  • 7.6.2 Antihistamines: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Nasal Delivery Devices Market Analysis – by Delivery Technologies

8.1 Spray
  • 8.1.1 Overview
  • 8.1.2 Spray: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Nebulizers
  • 8.2.1 Overview
  • 8.2.2 Nebulizers: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Inhalers
  • 8.3.1 Overview
  • 8.3.2 Inhalers: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Nasal Delivery Devices Market Analysis – by End User

9.1 Home Care Settings
  • 9.1.1 Overview
  • 9.1.2 Home Care Settings: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hospitals
  • 9.2.1 Overview
  • 9.2.2 Hospitals: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Clinics
  • 9.3.1 Overview
  • 9.3.2 Clinics: Europe Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Europe Nasal Delivery Devices Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Nasal Delivery Devices Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.2.1.1 Europe Nasal Delivery Devices Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 UK: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.1.2 UK: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.1.3 UK: Europe Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.2.2 Germany: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.2.3 Germany: Europe Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.3 France: Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 France: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.3.2 France: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.3.3 France: Europe Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.4 Russia: Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.4.2 Russia: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.4.3 Russia: Europe Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.5.2 Italy: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.5.3 Italy: Europe Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.6.2 Rest of Europe: Europe Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.6.3 Rest of Europe: Europe Nasal Delivery Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 GlaxoSmithKline plc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 AstraZeneca
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Pfizer Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Sanofi
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck & Co., Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Cadila Pharmaceuticals Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Novartis AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Nasal Delivery Devices Market

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddy's Laboratories
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)